Search Results 1471-1480 of 18138 for monoclonal antibody

1. Safety, Tolerability and Efficacy of AntiBKV as Treatment of BKV Infection in Kidney Transplant Recipients (SAFE KIDNEY II) - Mayo Clinic

   Recipients who, in the opinion of the investigator, are likely to require antibody-depletion therapy during trial participation. Antibody-depleting ...

2. A Study to Assess the Antitumor Activity and Safety of IMAB362 in Combination With Nab-Paclitaxel and Gemcitabine (Nab-P + GEM) as First Line Treatment in Subjects With Claudin 18.2 Positive, Metastatic Pancreatic Adenocarcinoma - Mayo Clinic

   ... monoclonal antibody, including humanized or chimeric antibodies. Subject has known immediate or delayed hypersensitivity, intolerance or contraindication to ...

3. Multiple myeloma - Doctors and departments - Mayo Clinic

   Associated Procedures. Bispecific antibody therapy · Bone marrow transplant · Cancer treatment · CAR-T cell therapy · Chemotherapy · Complete blood count (CBC) ...

4. Overview - Department of Immunology - Mayo Clinic Research

   Autoimmune diseases; Cancer; Chronic inflammation; Infections; Tissue transplantation. Two institutional core research resources, the Antibody Hybridoma Core ...

5. A Study Of PY314 In Subjects With Advanced Solid Tumors - Mayo Clinic

   Any anti-cancer therapy, including small molecules, immunotherapy, chemotherapy, monoclonal antibody therapy, radiotherapy, or any other agents to treat cancer ...

6. Clinical trials - Oncology (Medical)

   The purpose of this study is to assess the feasibility and develop procedures for detecting monoclonal proteins via finger pick blood spots and saliva. Data ...

7. A Study Of ANV419 Alone Or In Combination With Approved Treatment In Patients With Cutaneous Melanoma (OMNIA-1) - Mayo Clinic

   ... antibody or with anti-CTLA4 antibody in adult participants with advanced (unresectable or metastatic) cutaneous melanoma. Participation eligibility.

8. Oral AMXT 1501 Dicaprate in Combination With IV DFMO - Mayo Clinic

   Monoclonal antibodies: > 21 days must have elapsed from the infusion of last dose of antibody and toxicity related to antibody therapy must be recovered to ...

9. Clinical trials - Oncology (Medical)

   The purpose of this study is to determine the cellular and mechanistic basis of bone marrow hematopoietic dysfunction in untreated Monoclonal B Cell ...

10. Curcumin: Can it slow cancer growth? - Mayo Clinic

    ... Medical marijuana · Monoclonal antibody medicines for cancer: How they work · Mouth sores caused by cancer treatment: How to cope · MRI · Needle biopsy.